从无症状转变为症状的静心性慢性心力衰竭:过渡CHF的逻辑和设计
Anja Sandek1,2, Frank Edelmann3,4, Christoph Gertler1,2
1Clinic for Cardiology and Pneumology, Heart Research Center, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
ESC heart failure
|April 12, 2024
概括
这项研究调查了无症状缩功能障碍向症状性心力衰竭的进展. 了解这些机制对于开发新疗法来预防心力衰竭进展至关重要.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 临床试验 临床试验
背景情况:
- 慢性静心性心力衰竭 (CHF) 是一个重大的健康挑战.
- 无症状左心室功能障碍 (ALVSD) 在症状性心脏病发作之前或治疗后出现.
- 对ALVSD患者的临床过程和预后的了解仍然很少.
研究的目的:
- 了解从无症状到症状心力衰竭的进展.
- 确定预测ALVSD患者结果的机制和生物标志物.
- 为预防心力衰竭开发新型疗法提供信息.
主要方法:
- 过渡CHF研究是一项前性,多中心的纵向队列研究.
- 从20个德国心力衰竭诊所招募了1000名ALVSD患者 (LVEF ≤40%).
- 年度随访,评估主组合终点 (HF住院/心血管死亡) 和次要终点.
主要成果:
- 这项研究招募了1000名无症状左心室功能障碍患者.
- 每年对患者进行随访,以评估症状性心力衰竭的进展.
- 数据收集包括生物标志物,并发症和生活质量.
结论:
- 过渡CHF旨在阐明无症状缩功能障碍进展的病理生理学.
- 这些发现将有助于开发有针对性的疗法,以预防心力衰竭.
- 这项研究对于推进心力衰竭治疗模式至关重要.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Imaging Studies for Cardiovascular System I:Echocardiography
320
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
320


